NCT07916272 Coronary Myocardial Bridge and Coronary Plaques on MDCT
| NCT ID | NCT07916272 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sohag University |
| Condition | Myocardial Bridging |
| Study Type | OBSERVATIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-10-20 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50 participants in total. It began in 2026-10-20 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Myocardial bridging is a condition in which a segment of a coronary artery passes through the heart muscle instead of running on its surface. This study aims to determine the prevalence of coronary myocardial bridging and investigate its relationship with coronary atherosclerotic plaques using multidetector computed tomography coronary angiography (MDCT-CA). The study will include at least 50 patients referred for coronary CT angiography at Sohag University Hospital and New Sohag University Hospital. CT images will be evaluated to identify myocardial bridges, determine their location, measure their length and depth, and assess the presence, location, and characteristics of coronary atherosclerotic plaques. The findings will be analyzed to investigate the association between myocardial bridging and coronary atherosclerotic plaques.
Eligibility Criteria
Inclusion Criteria: * All patients referred to the Radiology Department of Sohag University Hospital and New Sohag University Hospital for coronary CT angiography. Exclusion Criteria: * Patients with contraindications to CT examination due to radiation-related risks. * Patients with known allergy to iodinated contrast media or impaired renal function (serum creatinine \> 1.5 mg/dL or estimated glomerular filtration rate \< 30 mL/min). * Patients with heart rate or rhythm incompatible with electrocardiographically gated scanning (heart rate \> 70 beats/min or uncontrolled atrial fibrillation). * Patients with an Agatston calcium score \> 400. * Uncooperative patients or those who do not provide informed consent
Frequently Asked Questions
Who can join the NCT07916272 clinical trial?
This trial is open to participants of all sexes, studying Myocardial Bridging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07916272 currently recruiting?
Yes, NCT07916272 is actively recruiting participants. Visit ClinicalTrials.gov or contact Sohag University to inquire about joining.
Where is the NCT07916272 trial being conducted?
This trial is being conducted at Sohag, Egypt.
Who is sponsoring the NCT07916272 clinical trial?
NCT07916272 is sponsored by Sohag University. The trial plans to enroll 50 participants.